Search Results
Dr. Jose Baselga Compares the mTOR Inhibitors Temsirolimus and Everolimus
Dr. Baselga Discusses Fine Tuning Drug Doses
Dr. Jose Baselga Describes the Investigation of pan-PI3 Kinase Inhibitors in Breast Cancer
Dr. Cohen on mTOR Inhibition in Head and Neck Cancer
Dr. Baselga Discusses Targeting PI3K in Breast Cancer
Keynote - Novel Therapeutics in Cancer (Jose Baselga)
Next Steps for Everolimus in ER-positive Metastatic Breast Cancer
Dr. Matthew Galsky on Fatal Adverse Events Associated With mTOR Inhibitors
Dr. Perez Discusses the BOLERO-2 Everolimus Trial
Management of mTOR Inhibitor Side Effects in Breast Cancer
ICON Meeting 2011: mTOR Inhibitors - Dr.Yao
Dr. Dizon on PTEN Mutations and mTOR Inhibitors in Endometrial Cancer
